These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8130316)

  • 1. The good, the bad and the obvious: 1993 Clemson Award for Basic Research--Keynote Lecture.
    Sefton MV
    Biomaterials; 1993 Dec; 14(15):1127-34. PubMed ID: 8130316
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-thrombogenicity of organic polymers by blending with alkylamine-heparin complexes.
    Kashiwagi T; Ito Y; Imanishi Y
    Biomaterials; 1993 Dec; 14(15):1145-53. PubMed ID: 8130319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of antithrombotic and thrombocytopenic effects of D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone in rabbits.
    Dundore RL; Clas DM; VanAller GS; Habeeb PG; Pagani ED
    Thromb Res; 1994 Sep; 75(6):663-6. PubMed ID: 7831686
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
    Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-resistant thrombus formation by endovascular stents in baboons. Interruption by a synthetic antithrombin.
    Krpski WC; Bass A; Kelly AB; Marzec UM; Hanson SR; Harker LA
    Circulation; 1990 Aug; 82(2):570-7. PubMed ID: 2372903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-poly(ethylene glycol)-poly(vinyl alcohol) hydrogel: preparation and assessment of thrombogenicity.
    Llanos GR; Sefton MV
    Biomaterials; 1992; 13(7):421-4. PubMed ID: 1633215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patency of heparin-PVA coated tubes at low flow rates.
    Ip WF; Sefton MV
    Biomaterials; 1989 Jul; 10(5):313-7. PubMed ID: 2765627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.
    Palekar RU; Vemuri C; Marsh JN; Arif B; Wickline SA
    J Vasc Surg; 2016 Nov; 64(5):1459-1467. PubMed ID: 26482989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
    Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3184-8. PubMed ID: 3362867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surface-immobilized heparin prevents platelet coagulation].
    Nystrand A
    Lakartidningen; 1991 Jan; 88(4):237-40. PubMed ID: 1994172
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis.
    André P; LaRocca T; Delaney SM; Lin PH; Vincent D; Sinha U; Conley PB; Phillips DR
    Circulation; 2003 Nov; 108(21):2697-703. PubMed ID: 14597584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method to give an antithrombogenicity to biological materials and its successful application to vascular grafts.
    Miyata T; Noishiki Y; Matsumae M; Yamane Y
    Trans Am Soc Artif Intern Organs; 1983; 29():363-8. PubMed ID: 6673254
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel thromboresistant materials.
    Jordan SW; Chaikof EL
    J Vasc Surg; 2007 Jun; 45 Suppl A():A104-15. PubMed ID: 17544031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymers modified by biologically active compounds--a new type of compatible material for contact with the blood].
    Platé NA; Valuev LI; Chutov VV; Burdygina IF
    Vopr Med Khim; 1985; 31(4):43-7. PubMed ID: 4049785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels.
    Yamashita T; Yamamoto J; Sasaki Y; Matsuoka A
    Thromb Res; 1993 Jan; 69(1):93-100. PubMed ID: 8465278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin functions and antithrombotic intervention.
    Fenton JW
    Thromb Haemost; 1995 Jul; 74(1):493-8. PubMed ID: 8578512
    [No Abstract]   [Full Text] [Related]  

  • 17. Local delivery of an antithrombin inhibits platelet-dependent thrombosis.
    Scott NA; Nunes GL; King SB; Harker LA; Hanson SR
    Circulation; 1994 Oct; 90(4):1951-5. PubMed ID: 7923684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thromboresistant properties of hydrophilic gels].
    Chepurov AK; Belomestnaia ZM; Donetskiĭ IA; Tsidvintseva FV; Eremin VN
    Polim Med; 1980; 10(3):121-33. PubMed ID: 7255286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agglutination of rabbit platelets in plasma by the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
    Packham MA; Bryant NL; Guccione MA
    Thromb Haemost; 1990 Apr; 63(2):282-5. PubMed ID: 2363129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessments of thrombogenicity by three in vitro techniques. Student Research Award in the Undergraduate, Master Candidate, or Health Science Degree Candidate Category, 21st annual meeting of the Society for Biomaterials, San Francisco, CA, March 18-22, 1995.
    Skarada DJ; Erickson GR; Warnecke KL; du Laney TV; Greenberg CS; Ritter EF; Klitzman B
    J Biomed Mater Res; 1995 Sep; 29(9):1039-45. PubMed ID: 8567701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.